|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2002-12-31
|
|
pubmed:abstractText |
The importance of chemotherapy in the treatment of gastric cancer has increased after the appearance of more effective new agents such as TS-1. Therefore, the development of second line chemotherapy following TS-1 administration is needed urgently. Recently, we treated three cases of advanced and recurrent gastric cancers, using paclitaxel after TS-1 treatment. We herein describe these cases and discuss the therapeutic effect of paclitaxel and drug-related side effects in these patients.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2555-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12506482-Aged,
pubmed-meshheading:12506482-Antimetabolites, Antineoplastic,
pubmed-meshheading:12506482-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:12506482-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12506482-Drug Administration Schedule,
pubmed-meshheading:12506482-Drug Combinations,
pubmed-meshheading:12506482-Female,
pubmed-meshheading:12506482-Humans,
pubmed-meshheading:12506482-Male,
pubmed-meshheading:12506482-Middle Aged,
pubmed-meshheading:12506482-Oxonic Acid,
pubmed-meshheading:12506482-Paclitaxel,
pubmed-meshheading:12506482-Pyridines,
pubmed-meshheading:12506482-Stomach Neoplasms,
pubmed-meshheading:12506482-Tegafur
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
[Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
|
|
pubmed:affiliation |
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
